Toppet M, Malfroot A, Derde M P, Toppet V, Spehl M, Dab I
Hôpital Universitaire Des Enfants Reine Fabiola, Université Libre de Bruxelles, Belgium.
Arch Dis Child. 1990 Nov;65(11):1222-6. doi: 10.1136/adc.65.11.1222.
The usefulness of prednisolone in combination with the modern potent antituberculous drugs has been studied in 29 children with primary lung tuberculosis and hilar adenopathy causing bronchial obstruction. These children were divided at random in two groups of 15 and 14 patients. Both groups were treated similarly except that one group received prednisolone. Both groups were very similar before the onset of treatment for most variables. Tuberculous infection healed in both groups but the group on steroids improved earlier and had significantly fewer complications, both on radiography and bronchoscopy. Only two of the patients on steroids still had progressive lesions: a very young baby probably because he developed two severe viral infections consecutively, and another infant of 7 months whose treatment was unreliable, as the parents were not very compliant. Some patients initially not treated with prednisolone improved only after it was given. Prednisolone treatment is not recommended when the reliability of the treatment cannot be guaranteed, as the hazard of harm would exceed the expected benefit.
在29例患有原发性肺结核和肺门淋巴结肿大导致支气管阻塞的儿童中,研究了泼尼松龙与现代强效抗结核药物联合使用的有效性。这些儿童被随机分为两组,一组15例,另一组14例。两组治疗方式相似,只是其中一组接受了泼尼松龙治疗。在大多数变量方面,两组在治疗开始前非常相似。两组的结核感染均已治愈,但使用类固醇的组改善得更早,在影像学和支气管镜检查方面并发症明显更少。使用类固醇的患者中只有两例仍有病变进展:一名非常年幼的婴儿可能是因为他连续发生了两次严重的病毒感染,另一名7个月大的婴儿,由于其父母不太配合,治疗不可靠。一些最初未接受泼尼松龙治疗的患者在使用后才有所改善。当治疗的可靠性无法保证时,不建议使用泼尼松龙治疗,因为危害风险将超过预期益处。